Bevacizumab synergises with the BCL 2 inhibitor venetoclax to effectively treat B-cell non-Hodgkin's lymphoma

Wang, L; Peng, SY; Sun, WP; Liu, XX

Liu, XX (reprint author), Southern Med Univ, Zhujiang Hosp, Dept Pharm, Guangzhou 510282, Guangdong, Peoples R China.

EUROPEAN JOURNAL OF HAEMATOLOGY, 2019; 103 (3): 234

Abstract

Objectives Our present study has shown a potential role for VEGF-A-mediated autocrine signalling to promote survival and proliferation of SU-DHL-6 cel......

Full Text Link